Counts show how tracked institutions changed this company in their latest available filings.
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
Greenlight Capital added 309,600 shares, but portfolio weight fell from 0.41% to 0.29% because the rest of the disclosed portfolio changed more.
Signals are derived from SEC EDGAR 13F information tables. Search aliases, tickers, themes, and company mappings help discovery but do not replace the original filing.
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
| Quarter | Current managers | Combined holding value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $9,467,030 | 1,646,440 | Greenlight Capital New position - 1,646,440 Shares |
| Q3 2025 | 1 | $9,384,708 | 1,646,440 | Greenlight Capital Unchanged - 1,646,440 Shares |
| Q4 2025 | 1 | $11,750,452 | 2,025,940 | Greenlight Capital Increased - 2,025,940 Shares |
| Q1 2026 | 1 | $9,202,027 | 2,335,540 | Greenlight Capital Increased - 2,335,540 Shares |
| Manager | Issuer | CUSIP | Security class | Holding market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Greenlight Capital | COYA THERAPEUTICS INC | 22407B108 | COMMON STOCK | $9,202,027 | 2,335,540 | 0.29% | SEC XML |